| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/10/2003 | CA2462162A1 Identification of new cd8 epitopes from hiv-1 proteins with therapeuticaal and vaccinal properties against hiv infections |
| 04/10/2003 | CA2462144A1 Micro-rna molecules |
| 04/10/2003 | CA2462119A1 Process for producing .alpha.1,4-galactosyltransferase and galactose-containing complex sugar |
| 04/10/2003 | CA2462113A1 Multi-chain eukaryotic display vectors and uses thereof |
| 04/10/2003 | CA2462077A1 Fluorescent proteins |
| 04/10/2003 | CA2462076A1 Esr2 - a plant gene that can promote plant regeneration and transformation |
| 04/10/2003 | CA2462017A1 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 04/10/2003 | CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | CA2461713A1 Sodium-independent transporter transporting small-sized neutral amino acid, gene thereof and method of analyzing transporter function by constructing fused proteins enabling the specification of the function |
| 04/10/2003 | CA2461606A1 Nonhuman mammal model of autoimmune disease having ox40l gene transferred thereinto |
| 04/10/2003 | CA2461292A1 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | CA2461267A1 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 04/10/2003 | CA2461254A1 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | CA2460917A1 Human tissue factor antibodies |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2460396A1 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 04/10/2003 | CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | CA2460257A1 Methods for diagnosing and treating heart disease |
| 04/10/2003 | CA2459133A1 Methods for generating, selecting, and identifying compounds which bind a target molecule |
| 04/10/2003 | CA2458818A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 04/10/2003 | CA2455389A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/09/2003 | EP1300473A1 Method of detecting nucleotide polymorphism |
| 04/09/2003 | EP1300469A1 Expression of laccase from basidiomyctes in transgenic plants |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300467A1 Novel polypeptide and dna thereof |
| 04/09/2003 | EP1300466A2 A cascade nucleic acid amplification reaction |
| 04/09/2003 | EP1300465A1 Process and apparatus for isolation of RNA samples |
| 04/09/2003 | EP1300463A1 Isolated nucleic acid molecules encoding SSX family members and uses thereof |
| 04/09/2003 | EP1300462A1 Reaction vessel, reaction device and temperature control method for reaction liquid |
| 04/09/2003 | EP1300419A1 Antibody of human origin for inhibiting thrombocyte aggregation |
| 04/09/2003 | EP1300417A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/09/2003 | EP1300161A1 Cationic lipids suitable for gene transfer |
| 04/09/2003 | EP1300158A1 Medicinal compositions for angiogenic therapy |
| 04/09/2003 | EP1300156A2 Otitis media vaccine |
| 04/09/2003 | EP1300082A2 Lysin of a bacteriophage of Clostridia spp |
| 04/09/2003 | EP1299728A2 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 04/09/2003 | EP1299727A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 04/09/2003 | EP1299564A2 Integrated microarray devices |
| 04/09/2003 | EP1299560A2 Identification and modulation of t helper-1 and t helper-2 cells |
| 04/09/2003 | EP1299557A1 Signal amplification with lollipop probes |
| 04/09/2003 | EP1299556A2 Host cells containing multiple integrating vectors |
| 04/09/2003 | EP1299555A2 Methods for enhancing plant transformation frequencies |
| 04/09/2003 | EP1299554A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 04/09/2003 | EP1299553A2 Modification of gene expression in transgenic plants |
| 04/09/2003 | EP1299552A2 Methods and compositions for simultaneous saccharification and fermentation |
| 04/09/2003 | EP1299551A2 7677, a novel human atpase family member and uses therefor |
| 04/09/2003 | EP1299550A2 Sinapoyglucose:malate sinapoyltransferase forms malate conjugates from benzoic acid glucosides |
| 04/09/2003 | EP1299549A1 Helicobacter pylori heptosyltransferase polynucleotides and polypeptides |
| 04/09/2003 | EP1299548A1 Novel therapeutic molecular variants and uses thereof |
| 04/09/2003 | EP1299547A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 04/09/2003 | EP1299546A2 Aminoacyl trna synthetases |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299544A2 Fimh adhesin proteins and methods of use |
| 04/09/2003 | EP1299543A2 Hypersensitive response eliciting domains of bacterial harpins and use thereof |
| 04/09/2003 | EP1299542A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299540A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 04/09/2003 | EP1299539A1 Myocardium-specific promoter |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299537A1 Compounds targeted to cellular locations |
| 04/09/2003 | EP1299536A1 Novel alpha-catenin expressed in heart and testis |
| 04/09/2003 | EP1299535A2 Peptide extended glycosylated polypeptides |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299533A2 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis |
| 04/09/2003 | EP1299532A1 Improved combinatorial libraries by recombination in yeast and analysis method |
| 04/09/2003 | EP1299531A2 Method for isolating nucleic acids |
| 04/09/2003 | EP1299530A2 Novel compounds |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 04/09/2003 | EP1299528A1 Human olfactory receptors and genes encoding same |
| 04/09/2003 | EP1299524A1 Human myeloma cell line |
| 04/09/2003 | EP1299522A2 Alteration of cell membrane |
| 04/09/2003 | EP1299421A2 Antibodies to human mcp-1 |
| 04/09/2003 | EP1299419A2 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299416A2 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 04/09/2003 | EP1299414A2 Fluorescent proteins |
| 04/09/2003 | EP1299413A2 Homogentisate phytyl transferase |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299411A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299407A2 Maize glutamine synthetase gene promoter |
| 04/09/2003 | EP1299327A2 Phosphorylated polypeptides and uses related thereto |
| 04/09/2003 | EP1299166A1 Polynucleotide separations on polymeric separation media |
| 04/09/2003 | EP1299126A2 Glutamic acid decarboxylase (gad) delivery system for treating neurodegenerative diseases |
| 04/09/2003 | EP1299116A2 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
| 04/09/2003 | EP1299032A1 DNA encoding human serine protease D-G |
| 04/09/2003 | EP1298991A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 04/09/2003 | EP1298988A2 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on intracellular receptors, and method for the preparation thereof |
| 04/09/2003 | EP1276500A4 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 04/09/2003 | EP1246833A4 Improved synthesis of sulfurized oligonucleotides |
| 04/09/2003 | EP1230342A4 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 04/09/2003 | EP1141417A4 A method of amplification of a circularised nucleic acid probe |
| 04/09/2003 | EP1083922B1 Composition and method for treatment of pseudomonas aeruginosa |
| 04/09/2003 | EP1077599A4 PARTICLE BOMBARDMENT TRANSFORMATION OF $i(BRASSICA) |
| 04/09/2003 | EP0954524B1 Process for purifying apolipoproteins |
| 04/09/2003 | EP0943019B1 Sets of labeled energy transfer fluorescent primers and their use in multi component analysis |
| 04/09/2003 | EP0844910B1 Machine for synthesizing oligonucleotides |
| 04/09/2003 | EP0840748B1 Transforming growth factor beta crystals |
| 04/09/2003 | EP0808320B1 Novel chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation |